What this quiz covers
This quiz focuses on Research And Development Costs, giving you a quick way to practice the rules, question types, and explanations that matter most for CPA Financial Accounting and Reporting Far.
On January 1, Year 1, Apex Industries purchased a specialized machine for $500,000 to be used in its research and development department. The machine has an estimated useful life of 5 years and a salvage value of $50,000. The machine can be used in the company's regular production activities after the current R&D project is completed in two years. Apex uses the straight-line method of depreciation.
What amount of expense related to this machine should Apex include in its research and development expense for Year 1?
CPA Financial Accounting and Reporting Far Quiz
Practice Research And Development Costs in CPA Financial Accounting and Reporting Far with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
This quiz focuses on Research And Development Costs, giving you a quick way to practice the rules, question types, and explanations that matter most for CPA Financial Accounting and Reporting Far.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
On January 1, Year 1, Apex Industries purchased a specialized machine for $500,000 to be used in its research and development department. The machine has an estimated useful life of 5 years and a salvage value of $50,000. The machine can be used in the company's regular production activities after the current R&D project is completed in two years. Apex uses the straight-line method of depreciation.
What amount of expense related to this machine should Apex include in its research and development expense for Year 1?
Explanation: When an asset purchased for R&D activities has an alternative future use, its cost should be capitalized. The depreciation on the asset is then allocated to R&D expense for the periods it is used in R&D. The annual straight-line depreciation is calculated as (Cost - Salvage Value) / Useful Life. In this case, it is ($500,000 - $50,000) / 5 years = $90,000 per year. This amount is the R&D expense for Year 1.
Cortex Software is developing a new software product to be sold to customers. During the year, the company incurred $150,000 in costs related to planning, designing, and testing activities that occurred before technological feasibility was established.
How should Cortex Software account for the $150,000 of costs incurred?
Explanation: For software to be sold, leased, or otherwise marketed, all costs incurred to establish technological feasibility are considered research and development costs. Therefore, they must be expensed as incurred. Capitalization of software development costs begins only after technological feasibility has been established.
Nimbus Tech Inc. is developing a new software product to be sold. During the year, Nimbus incurred the following costs:
What is the total amount of costs that Nimbus should capitalize as a software development asset for the year?
Explanation: Costs incurred after technological feasibility has been established but before the product is available for general release to customers should be capitalized. This includes coding and testing after feasibility (200,000)andtheproductionofproductmasters(30,000). The total amount to be capitalized is $200,000 + $30,000 = 230,000.Costsincurredbeforetechnologicalfeasibility(50,000 + $120,000) must be expensed as R&D.
Venture Corp. paid $400,000 to acquire a specific research project from another company. The transaction was an asset acquisition, not a business combination. The assets acquired in the project have no alternative future use for Venture Corp.
What is the correct accounting treatment for the $400,000 payment by Venture Corp.?
Explanation: When R&D is acquired in a transaction other than a business combination (i.e., an asset acquisition), the treatment depends on whether the assets have an alternative future use. If, as in this case, there is no alternative future use, the entire cost must be expensed immediately as research and development expense.
A company has just completed the R&D phase for a new, patentable manufacturing process. The company incurred $500,000 in R&D costs to develop the process. In addition, the company paid $35,000 in legal and filing fees to secure the patent.
What is the total amount of costs that should be capitalized as an intangible asset related to the new process?
Explanation: Under U.S. GAAP, all internal R&D costs (500,000)incurredtodevelopaproductorprocessmustbeexpensedasincurred.However,thelegalfeesandotherdirectcostsassociatedwithsecuringapatent(35,000) are capitalized as an intangible asset (the patent) and amortized over its legal or useful life, whichever is shorter.
Which of the following activities would be excluded from research and development costs under U.S. GAAP?
Explanation: ASC 730 explicitly excludes routine or periodic alterations to existing products, production lines, manufacturing processes, and other on-going operations from the definition of R&D. The other three options (conceptual formulation, prototype design/testing, and laboratory research) are core examples of activities that are included in R&D.
On January 1, Year 1, ByteCorp capitalized $600,000 of software development costs for a new product with an estimated five-year useful life. The software was made available for sale on this date. In Year 1, revenues from the software were $200,000. Total anticipated revenues over the software's life are $1,000,000.
What is the correct amount of amortization expense for the capitalized software that ByteCorp should record for Year 1?
Explanation: Amortization of capitalized software costs is the greater of the amount computed by (1) the straight-line method or (2) the ratio of current gross revenues to total anticipated gross revenues.
At December 31, Year 2, a company's balance sheet included capitalized software costs of $800,000. Due to a new competitor, the expected future net cash flows from the software are estimated to be only $500,000. The fair value of the software is estimated at $450,000.
What journal entry should the company record at December 31, Year 2?
Explanation: Capitalized software costs are tested for impairment by comparing the carrying amount to the net realizable value (NRV). NRV is the estimated future net cash flows from the product. Since the carrying amount (800,000)exceedstheNRV(500,000), an impairment loss of 300,000(800,000 - $500,000) must be recognized. The entry is: Debit Impairment Loss $300,000; Credit Capitalized Software Costs $300,000.
After completing research and development on a new manufacturing process, a company incurred additional costs for troubleshooting issues that arose during the initial commercial production run.
How should the company account for these troubleshooting costs?
Explanation: Costs incurred during the start-up of commercial production are explicitly excluded from the definition of research and development. These costs, such as troubleshooting production issues, are considered normal operating expenses (either manufacturing overhead or a period cost) and should be expensed as incurred.
Zenith Corp. had the following project costs during the year:
What is the total research and development expense Zenith Corp. should report for the year?
Explanation: R&D expense is calculated by summing the costs that qualify under GAAP. This includes: all costs for Project Alpha (basic research) of 300,000,plusthecostsforProjectBetaincurredbeforetechnologicalfeasibility(100,000). The costs for Project Gamma (routine follow-through) are excluded from R&D. The costs for Project Beta after feasibility ($150,000) are capitalized. Total R&D expense = $300,000 + $100,000 = $400,000.
Quantum Labs performs contract research and development services for other companies. During the year, Quantum was paid $500,000 by a major pharmaceutical company to conduct a clinical trial. Quantum incurred $350,000 of costs (salaries, materials, etc.) in performing this service.
How should Quantum Labs classify the $350,000 of costs incurred in its income statement?
Explanation: The costs of R&D activities performed for others under a contract are not considered R&D expenses for the entity performing the work. Instead, these costs are accounted for as the cost of services provided (similar to cost of goods sold) and are matched with the revenue from the contract.
A company is developing a new enterprise resource planning (ERP) system for its own internal use. The project has several stages.
At which point should the company begin capitalizing the direct costs of materials and services and the payroll costs for employees working on the project?
Explanation: For internal-use software, capitalization begins after the preliminary project stage is complete and when management, with the relevant authority, implicitly or explicitly authorizes and commits to funding the project, and it is probable that the project will be completed and the software will be used to perform its intended function. Costs in the preliminary stage are expensed. The 'technological feasibility' milestone applies to software developed for external sale, not internal use.
ChemCo received a $1,000,000 grant from a government agency to perform research on a new biodegradable plastic. During the year, ChemCo incurred $750,000 of qualifying R&D expenditures under the terms of the grant.
How should ChemCo report the $750,000 of R&D expenditures in its income statement?
Explanation: Under U.S. GAAP, R&D costs are expensed as incurred, regardless of the source of funding. The grant from the government does not change the nature of the expenditure. ChemCo must report $750,000 as R&D expense. The accounting for the grant itself would typically involve recognizing a liability and then recognizing income (e.g., other income) as the related expenses are incurred, but the R&D expense classification is unaffected.
A corporation's research and development department is housed in a building that is also used by the company's manufacturing and administrative departments. The total depreciation expense on the building for the year is $200,000. The R&D department occupies 25% of the building's space.
What is the appropriate accounting treatment for the building's depreciation expense?
Explanation: Indirect costs, such as depreciation on a shared facility, should be allocated on a reasonable basis to the functions that benefit from them. A reasonable allocation of the building's depreciation should be made to R&D expense. Allocating based on space occupied is a reasonable method. Therefore, 25% of $200,000, which is $50,000, should be included in R&D expense.
Proton Inc. incurred significant costs related to a radical redesign of its flagship product to incorporate new technology, which is expected to double the product's efficiency.
How should Proton Inc. account for the costs associated with this radical redesign?
Explanation: While routine or periodic alterations to existing products are excluded from R&D, significant improvements or radical redesigns that involve new technology fall under the definition of research and development activities. Therefore, these costs should be expensed as R&D as incurred.
Mega Corp. acquired a smaller company, Innovate Co., in a business combination. As part of the acquisition, Mega Corp. acquired an in-process research and development (IPR&D) project from Innovate. The project has not yet reached technological feasibility and has no alternative future use. The fair value of the IPR&D project was determined to be $2,000,000.
How should Mega Corp. account for the $2,000,000 of acquired IPR&D?
Explanation: In a business combination, acquired in-process research and development (IPR&D) is recognized as an asset separate from goodwill at its acquisition-date fair value. Since the project has not yet reached technological feasibility, it is considered an indefinite-lived intangible asset and is not amortized but is tested for impairment annually until the project is completed or abandoned.
Helix BioTech Inc. purchased highly specialized equipment for $220,000 for use in a single, specific research and development project. The equipment has no alternative future use for Helix after the project is completed, and its salvage value is considered negligible.
What is the appropriate accounting treatment for the cost of this equipment in the year of purchase?
Explanation: According to U.S. GAAP, the cost of materials, equipment, or facilities that are acquired for a particular R&D project and have no alternative future use should be expensed as R&D in the period the costs are incurred. Since the equipment has no alternative use, its entire cost of $220,000 is included in R&D expense for the year.
During the current year, Nova Corp. incurred the following costs related to the development of a new product:
Based on the information provided, what is the total amount Nova Corp. should report as research and development expense for the current year?
Explanation: Research and development (R&D) expense includes costs directly attributable to R&D activities. The calculation is as follows: Salaries of R&D personnel (250,000) + Materials consumed in R&D (90,000) + Depreciation on equipment used exclusively for R&D ($40,000) = $380,000. Marketing research, quality control during commercial production, and legal fees for a patent application are explicitly excluded from R&D expense. Patent legal fees are capitalized as an intangible asset.
During the current year, Nova Corp. incurred the following costs related to the development of a new product:
Based on the information provided, what is the total amount Nova Corp. should report as research and development expense for the current year?
Explanation: Research and development (R&D) expense includes costs directly attributable to R&D activities. The calculation is as follows: Salaries of R&D personnel (250,000) + Materials consumed in R&D (90,000) + Depreciation on equipment used exclusively for R&D ($40,000) = $380,000. Marketing research, quality control during commercial production, and legal fees for a patent application are explicitly excluded from R&D expense. Patent legal fees are capitalized as an intangible asset.
On January 1, Year 1, Apex Industries purchased a specialized machine for $500,000 to be used in its research and development department. The machine has an estimated useful life of 5 years and a salvage value of $50,000. The machine can be used in the company's regular production activities after the current R&D project is completed in two years. Apex uses the straight-line method of depreciation.
What amount of expense related to this machine should Apex include in its research and development expense for Year 1?
Explanation: When an asset purchased for R&D activities has an alternative future use, its cost should be capitalized. The depreciation on the asset is then allocated to R&D expense for the periods it is used in R&D. The annual straight-line depreciation is calculated as (Cost - Salvage Value) / Useful Life. In this case, it is ($500,000 - $50,000) / 5 years = $90,000 per year. This amount is the R&D expense for Year 1.